Legal Opinion

In re Watson Fentanyl Patch Products Liability Litigation

United States Judicial Panel on Multidistrict Litigation

Decided August 7, 2012No. MDL No. 2372PublishedCited by 37 opinions

1Opinion of the Court

TRANSFER ORDER

JOHN G. HEYBURN II, Chairman.

Before the Panel: Pursuant to 28 U.S.C. § 1407, plaintiffs in 22 actions that involve injuries arising from the use of allegedly defective Watson fentanyl patches move to centralize this litigation in the Northern District of Illinois. This litigation currently consists of 22 actions pending in fifteen districts, as listed on Schedule A.1

Watson defendants2 support centralization of all fentanyl patch litigation, not just *1351the actions against Watson. Watson suggests that we select one of three districts in which no action is pending — the Northern…

2Cases cited2 opinions

  1. In re Yellow Brass Plumbing Component Products Liability LitigationUnited States Judicial Panel on Multidistrict Litigation · 2012
  2. In Re ClassicStar Mare Lease LitigationUnited States Judicial Panel on Multidistrict Litigation · 2007

3Cited by37 opinions

  1. In re Invokana (CANAGLIFLOZIN) Products Liability LitigationUnited States Judicial Panel on Multidistrict Litigation · 2016
  2. In re Zostavax (Zoster Vaccine Live) Prods. Liab. Litig.United States Judicial Panel on Multidistrict Litigation · 2018
  3. Bokhari v. Torrent Pharmaceuticals LimitedDistrict Court, N.D. California · 2020
  4. Bon Secours Mercy Health, Inc. v. Blue Cross Blue Shield AssociationDistrict Court, N.D. Alabama · 2025
  5. Bon Secours Mercy Health, Inc. v. Blue Cross Blue Shield AssociationDistrict Court, N.D. California · 2025

32 more not listed; retrieve them via the Exa API.

Showing a preview — retrieve the full document via the Exa API.

Powered by the Exa API